Codiak BioSciences (NASDAQ:CDAK) reported quarterly losses of $(0.99) per share. The company reported $890.00 thousand in sales this quarter. This is a 375.94 percent increase over sales of $187.00 thousand the same period last year.
Codiak BioSciences Q2 EPS $(0.99), Sales $890.00K Up From $187.00K YoY
Codiak BioSciences (NASDAQ:CDAK) reported quarterly losses of $(0.99) per share. The company reported $890.00 thousand in sales this quarter. This is a 375.94 percent increase over sales of $187.00 thousand the same
